Company Filing History:
Years Active: 1980
Title: Eugene W Byrnes: Innovation in Pharmaceutical Chemistry
Introduction
Eugene W Byrnes is a notable inventor based in Holden, MA, with a focus on pharmaceutical chemistry. He holds two patents, showcasing his contributions to the field and highlighting the importance of innovation within the pharmaceutical industry.
Latest Patents
One of Eugene's latest patents is centered around primary amino acylanilides, a class of compounds characterized by a complex chemical formula. The specifics of his invention include variations where R1 can be hydrogen, methyl, ethyl, or propyl, while R2 encompasses methyl, ethyl, chlorine, methoxy, and ethoxy. Additional variables, including R3 through R10, allow for a versatile range of applications. This invention focuses on the methods of making primary amino acylanilides and their various uses, reflecting a significant advancement in pharmaceutical research.
Career Highlights
Eugene W Byrnes is associated with Astra Pharmaceutical Products, Inc., a company known for its innovation in creating life-saving medications. His work there significantly impacts drug development, emphasizing the vital role inventors play in enhancing pharmaceutical efficacy and safety.
Collaborations
Throughout his career, Eugene has collaborated with esteemed colleagues such as Robert N Boyes and Benjamin R Duce. These collaborations highlight the collective efforts in advancing pharmaceutical science and the importance of teamwork in innovation.
Conclusion
Eugene W Byrnes represents the ingenuity and dedication found within the field of pharmaceutical innovation. His patents and collaborations underscore the critical nature of continued research and development in improving health outcomes through innovative solutions.